top of page
Profile
Join date: Mar 20, 2023
Posts (27)
Oct 27, 2025 ∙ 2 min
Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events
NEW YORK--( BUSINESS WIRE )--Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the Jefferies Healthcare Conference, two of the world’s premier partnering events for the Life Sciences industry. “These two conferences are excellent opportunities to engage with forward-thinking leaders and companies seeking innovative solutions to advance drug development,”...
47
0
Feb 11, 2025 ∙ 2 min
Laxxon's New Generation Levodopa/Carbidopa Treatment, LXM.5, Granted Funding by ESF Plus and the Free State of Thuringia
Laxxon's New Generation Levodopa/Carbidopa for Parkinson's Disease project, LXM.5, has been awarded a grant.
60
0
Feb 4, 2025 ∙ 3 min
Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LXM.5
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery...
352
0
Laxxon Medical
Writer
More actions
bottom of page